Remarkably, they found that PI4KIIIαloss prevents the Hippo component Merlin (Mer) (Neurofibromatosis Type-2 or NF2 in humans) from localizing to the apical domain, which consequently impairs Hippo signaling and activates Yki. The gene discussed is NF2; the disease is neurofibromatosis.